Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-92

No : your wrong
Iv’e looked into it .. again and again with my family members …

Trial results 6 months after lastpatient enrolment early 3Q'23

More than 3 quarters beforeoppies expire …in Dec 2024

This is a good announcement
Why?
We will have a definite result in the 2 nd 1/4 2024
So people will know 9 +months ..prior to the expirary of the 48c options…
But in the meantime we have all the other results.. Long covid
Limb girdle
Long Covid
Combination therapy etc
Do you guys honestly believe that the sp will be around 10c in late 2023….
No No No….
So
It was unethical to start a trial in DMD without having the full finance in place.
We wanted the ANP Board to think outside the box and keep the Clinical trial moving forward..
These are hard times…
And today the Board delivered…
Most on here know we are moving to a MC of $1 billion in the next year and a half..Why is everyone upset.
The Anp Board are confident in the Science…and believe we will Replicate the last trial results..
Then it’s up to the European Medical Agency to give us a fast approval to Commercialisation..
FDA could follow as well…
So at the end of the day
We could be in a sweet spot come mid 2024…
$$$$$